Purchase Order HHSN272201400248P
Award Date 1/20/14
Potential Completion Date 1/19/15
Potential Value $51K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- This federal contract award is for site-directed mutagenesis services (Catalog #GI-M100) provided by Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, MD. The $9,994.40 firm fixed price contract was awarded on September 22, 2010 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). The contract has an ultimate completion date of September 30, 2010 and does not have a set-aside designation. Geneimmune Biotechnology Corp....
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The contract has a potential value of $12,265.00 and is focused on DNA preparation services. The contract was set aside for small businesses and does not appear to be associated with a larger contract vehicle. Geneimmune...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, MD. The contract is for $151,620.00 and covers site-directed mutagenesis, gene synthesis, and plasmid preparation services in support of COVID-19 research. The contract was awarded on a sole-source basis pursuant to FAR...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
- The National Institute of Allergy and Infectious Diseases awarded a $149,959.70 firm fixed-price purchase order to Geneuniversal Inc. on September 8, 2021, for gene synthesis, site-directed mutagenesis, PCR cloning, and plasmid preparation services. The contract, with an ultimate completion date of September 7, 2022, was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to GeneUniversal Inc., a small business located in Newark, Delaware. The $99,794.60 contract is for gene synthesis services, including subcloning, site-directed mutagenesis, PCR cloning, and plasmid preparation. The contract is not set aside and was awarded on a sole source basis, as NIAID determined GeneUniversal...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. on August 23, 2023, for DNA services valued at $34,502.16. The order covers gene synthesis, VectorArk cloning, and express plasmid preparation. Performance occurs in Piscataway, New Jersey. The services support development of peptide and protein immunogens and DNA constructs for MPER-scaffolded proteins used in vaccine research against HIV, influenza, Ebola, Marburg, and other infectious...